Lasmiditan Discontinuation, DAAN Designation, Alteplase for Eye Stroke

In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about the discontinuation of lasmiditan, the new DAAN designation, and the use of alteplase after eye stroke.